Edaravone - Citicoline comparative study in acute ischemic stroke (ECCS- AIS)

Journal of Association of Physicians of India

Volumn 60, Issue 11, 2012, Pages 36-38

  Mittal, Manish ^a   Goel, Deepak ^a   Bansal, Krishan K ^a   Puri, Prashant ^a  

^a HIMALAYAN INSTITUTE HOSPITAL TRUST   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CITICOLINE; DRUG DERIVATIVE; NEUROPROTECTIVE AGENT; PHENAZONE; PHENYLMETHYLPYRAZOLONE;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIPYRINE; BRAIN ISCHEMIA; CYTIDINE DIPHOSPHATE CHOLINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; STROKE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84869237239     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
2. Adams HP, Zoppo GD, Alberts MJ, Bhatt DL. Guidelines for the early management of adults with ischemic stroke. Circulation 2007;115:478-534.
3. Rebecca L. An acute need for better stroke care. Lancet Neurology 2007;6:1.
4. Nandigam K, Narayan SK, Elangovan S, Dutta TK, Sethuraman KR, Das AK. Feasibility of acute thrombolytic therapy for stroke. Neurology India 2003;51:470-73.
5. Eiichi Otomo. Effect of a Novel Free Radical Scavenger, Edaravone(MCI-186), on Acute Brain Infarction. Cerebrovasc Dis 2003;15:222-229.
6. Davalos A, Castillo J, Alvarez-Sabin J, Secades JJ, Mercadal J, Lopez S, Cobo E, Warach S, Sherman D, Clark WM, Lozano R. Oral citicoline in acute ischemic stroke: An individual patient data pooling analysis of clinical trials. Stroke 2002;33:2850-2857.
7. Clark WM, Warach SJ, Pettigrew LC, Gammans RE, Sabounjian LA. Citicoline Stroke Study Group. A randomized dose-response trial of citicoline in acute ischemic stroke patients. Neurology 1997;49:671-678.
8. Clark WM, Williams BJ, Selzer KA, Zweifler RM, Sabounjian LA, Gammans RE. A randomized efficacy trial of citicoline in patients with acute ischemic stroke. Stroke 1999;30:2592-2597.
9. Clark WM, Wechsler LR, Sabounjian LA, Schwiderski UE. Citicoline Stroke Study Group. A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients. Neurology 2001;57:1595-1602.
10. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischemic stroke: An integrated view. Trends Neurosci 1999;22:391-397.
11. Green AR, Ashwood T. Free radical trapping as a therapeutic approach to neuroprotection in stroke: Experimental and clinical studies with NXY-059 and free radical scavengers. Curr Drug Targets CNS Neurol Disord 2005;4:109-118.
12. Lees KR, Zivin JA, Ashwood T, Davalos A, Davis SM, Diener HC, Grotta J, Lyden P, Shuaib A, Hardemark HG, Wasiewski WW. NXY-059 for acute ischemic stroke. N Engl J Med 2006;354:588-600.
13. Hankey GJ, Langhorne P. Services for Reducing the Duration of Hospital Care for Acute Stroke Patients. Stroke 2006;37:276-277.